drug discovery

Showing 15 posts of 26 posts found.

ELRIG appoints Del Trezise as chair

April 8, 2025
Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …

Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University

July 31, 2024
Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …

Certara to acquire Chemaxon for drug discovery portfolio

July 10, 2024
Business Services Certara, Chemaxon, Pharmacy, acquisition, drug discovery

Certara and Chemaxon have announced that they have signed a definitive agreement under which Certara will acquire Chemaxon. The deal …

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024
Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.

Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development

March 15, 2024
Research and Development Allumiqs, Pharmacy, drug discovery, partnership

Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …

Isomorphic Labs to collaborate with Eli Lilly

January 11, 2024
Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery

Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …

Galapagos and BridGene Biosciences enter collaboration for oncology drug discovery

January 4, 2024
Research and Development BridGene Biosciences, Galapagos, Oncology, drug discovery, oncology

Galapagos NV and BridGene Biosciences have announced that they have entered into a strategic collaboration and licensing agreement for the …

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023
Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …

Recursion and NVIDIA partner for AI-enabled drug discovery developments

July 13, 2023
Research and Development AI, Pharmacy, Recursion, drug discovery

Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …

laboratory-testing-az

New screening method set to speed up drug discovery in major diseases

July 8, 2021
drug discovery

Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …

PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes

May 17, 2021
Sales and Marketing AI, drug discovery

PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …

Facio Therapies announces AI collaboration for FSHD drug design

May 11, 2021
Manufacturing and Production AI, drug discovery

Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …

gilead-sciences

Gilead invests $5.1 billion into Galapagos NV

July 15, 2019
Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma

Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …

amgen_flag

Amgen agrees to buy Nuevolution for $167 million

May 22, 2019
Research and Development Amgen, Cancer, Nuevolution, biotech, drug discovery, immuno-oncology, immunology, pharma

California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million). The …

celgene_1_02

Celgene inks drug discovery deal worth at least £25m with AI firm Exscientia

March 21, 2019
Research and Development Celgene, Exscientia, drug discovery, pharma

Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value …

The Gateway to Local Adoption Series

Latest content